{"name":"Velicept Therapeutics, Inc.","slug":"velicept-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Formulation 1 solabegron","genericName":"Formulation 1 solabegron","slug":"formulation-1-solabegron","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Formulation 1 solabegron","genericName":"Formulation 1 solabegron","slug":"formulation-1-solabegron","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxPUkFPanBvZTNZNXVsNjA4TjVIX3UxejJRa3hkanhiQ2pMTm9LNVpIZEtTcGJmZDd0eTNLdjFFbmNZdjN0N1FBUUFKS1dZYUtDOUJqeXdPTXRxSElES1RTcGRmU3RiZFMwa2VMTjJVazdfOGpSOEhOa2Y2SmF0dnZ5S25LSTdmN09iM0l6ay1qR3BtblVqRUJRcHYtSFBJZDZoSnRzR0tPbFZGbEYzZUprMjhzdDJ6TGNQc1ZQSURUWTFWLURWcENBcjRLUDN5QjB5RUo2RDE1bFhWRTQ0RVBrWGY5cVdtZ1hpSUhVU3ZmeE9xejNwTy1MNC01SG1BZV83eTlPdFhn?oc=5","date":"2021-06-08","type":"trial","source":"GlobeNewswire","summary":"Overactive Bladder Pipeline Shows Rapid Advancements in the Clinical Trials: A Review by DelveInsight - GlobeNewswire","headline":"Overactive Bladder Pipeline Shows Rapid Advancements in the Clinical Trials: A Review by DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPM1ZSVmRuRGt0RjdNZ09jOHZDbHRpQktTbXJrVkIteHlLZUFWMlBNT0IzbEpCaXAwcDA0Y3BSWXU2R042bmlQSjQwemFUN3Z4X1FhWU9qX2tTa2dWRUZYeUJXbmEwd2dpU1Y2VjlQV2dPRlg5WGFnV1VBYmNKZTc4eG1zaTRHbE1kQXFMemFUM0E?oc=5","date":"2015-06-15","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"AltheRx Merging Into New Company to Advance Solabegron - Genetic Engineering and Biotechnology News","headline":"AltheRx Merging Into New Company to Advance Solabegron","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}